DaVita healthCare Partners (DVA) : Money flow in the DaVita healthCare Partners (DVA) stock was negative (1.38 million) on Tuesday, which shows that the investors used the strength in the stock price to reduce their holdings. The total traded value on upticks was $10.09 million, compared to $11.47 million on downticks. The total uptick to downtick ratio was 0.88, indicating the underlying weakness in the stock. Even in block trades, money flow was negative ($1.36 million), indicating selling on the strength. Downtick transaction value in block trades amounted to $1.36 million, indicating persistent selling. DaVita healthCare Partners (DVA) traded $0.19 higher at $64.6 gaining 0.29% over the previous days close.
Also, In the latest statement by the brokerage house, JP Morgan maintains its outlook on DaVita healthCare Partners (NYSE:DVA). The current rating of the shares is Neutral, according to the research report released by the firm. The brokerage firm raises the price target from $74 per share to $75 per share. The rating by the firm was issued on August 9, 2016.
DaVita HealthCare Partners Inc. has lost 1.21% in the last five trading days and dropped 16.03% in the last 4 weeks. DaVita HealthCare Partners Inc. has dropped 16.6% during the last 3-month period . Year-to-Date the stock performance stands at -7.24%.
DaVita healthCare Partners (NYSE:DVA): During Tuesdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $64.32 and $64.32 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $64.84. The buying momentum continued till the end and the stock did not give up its gains. It closed at $64.66, notching a gain of 0.39% for the day. The total traded volume was 1,404,239 . The stock had closed at $64.41 on the previous day.
In a related news, The Securities and Exchange Commission has divulged that Staffieri Michael David, officer (COO, Kidney Care) of Davita Healthcare Partners Inc., had unloaded 20,262 shares at an average price of $73.09 in a transaction dated on August 9, 2016. The total value of the transaction was worth $1,480,950.
DaVita HealthCare Partners Inc. consists of two divisions, Kidney Care and HealthCare Partners (HCP). Kidney Care is a provider of dialysis services in the United States, treating patients with chronic kidney failure and end stage renal disease (ESRD). Kidney Care division develops innovative clinical care, offers integrated treatment plans, personalized care teams and health-management services. As of December 31, 2014, we provided dialysis and administrative services in the U.S. through a network of 2,179 outpatient dialysis centers in 46 states and the District of Columbia, serving a total of approximately 173,000 patients. HealthCare Partners division is a patient- and physician-focused integrated health care delivery and management company. HealthCare Partners manages and operates medical groups and affiliated physician networks in Arizona, California, Nevada, Florida and New Mexico. As of December 2014, HealthCare Partners had approximately 837,000 members under its care.